Long-term Active Surveillance Study for Oral Contraceptives (LASS)
NCT00676065 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 58303
Last updated 2014-11-19
Summary
The objective of this study is to characterize and compare the risks of long-term use of oral contraceptives containing drospirenone and of other established oral contraceptives.
Conditions
- Arterial Thromboembolism
- Venous Thromboembolism
- Breast Cancer
Sponsors & Collaborators
- collaborator INDUSTRY
-
Center for Epidemiology and Health Research, Germany
lead OTHER
Principal Investigators
-
Juergen Dinger, MD, PhD · Center for Epidemiology and Health Research Berlin, Germany
Eligibility
- Sex
- FEMALE
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2001-02-28
- Primary Completion
- 2011-03-31
- Completion
- 2011-12-31
Countries
- Germany
Study Locations
More Related Trials
-
International Active Surveillance Study - Safety of Contraceptives: Role of Estrogens
NCT01009684 ·Status: COMPLETED
-
Study to Investigate Efficacy and Safety of a New Oral Contraceptive
NCT00185289 ·Status: COMPLETED ·Phase: PHASE3
-
International Active Surveillance Study: Native Estrogen Estetrol (E4) Safety Study
NCT06028555 ·Status: RECRUITING
-
Open-Label Study to Evaluate the Safety and Efficacy of a Low-Dose 28-Day Oral Contraceptive
NCT00362479 ·Status: COMPLETED ·Phase: PHASE3
-
Observational Trial With Leios/Alesse
NCT00481650 ·Status: COMPLETED
-
A Multicenter Study to Evaluate the Effects of a 91-Day Extended Cycle Oral Contraceptive on Hemostatic Parameters in Healthy Women
NCT01252186 ·Status: COMPLETED ·Phase: PHASE2
-
Open-label Study to Evaluate the Efficacy and Safety of an Extended-cycle, Low Dose Combination Oral Contraceptive
NCT00196326 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of Lanabecestat in Healthy Female Participants Taking Oral Contraceptive
NCT03506399 ·Status: WITHDRAWN ·Phase: PHASE1
-
A Study to Investigate the Pharmacokinetics of Ethinyl Estradiol and Levonorgestrel When Given Alone and in Combination With Baxdrostat in Healthy Females of Non-childbearing Potential
NCT06657105 ·Status: COMPLETED ·Phase: PHASE1
-
INAS-FOCUS (International Active Surveillance Study - Folate in Oral Contraceptives Utilization Study)
NCT01266408 ·Status: COMPLETED
-
Drug-drug Interaction Study: Influence of Vilaprisan on Pharmacodynamics (PD) and Pharmacokinetics (PK) of a Combined Oral Contraceptive (COC)
NCT03210246 ·Status: COMPLETED ·Phase: PHASE1
-
Comparative Trial in Hormone Withdrawal Associated Symptoms
NCT01076582 ·Status: COMPLETED ·Phase: PHASE3
-
Investigate Impact of Yasmin vs Microgynon on Hemostasis Parameters in Healthy Women
NCT00651846 ·Status: COMPLETED ·Phase: PHASE4
-
A Multinational Study to Evaluate the Effects of a 28-Day Oral Contraceptive on Hemostatic Parameters in Healthy Women
NCT01388491 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Evaluate Inhibition of Ovulation of Two Oral Estrogen/Progestogen Regimens in Healthy, Young Females Over a Period of 3 Treatment Cycles
NCT00631124 ·Status: COMPLETED ·Phase: PHASE2
-
European Active Surveillance Study of Women Taking Hormone Replacement Therapy (HRT)
NCT00214903 ·Status: COMPLETED
-
A Study to Assess the Effect of Venetoclax on Ethinyl Estradiol and Levonorgestrel in Female Participants With Different Hematological Malignancies
NCT03557619 ·Status: RECRUITING ·Phase: PHASE1
-
A Study to Evaluate the Drug-drug Interaction of BMS-986196 With Oral Contraceptives in Healthy Female Participants
NCT05891262 ·Status: COMPLETED ·Phase: PHASE1
-
Evaluate the Pharmacokinetics of a Combined Oral Contraceptive (COC) With and Without Obicetrapib
NCT06250205 ·Status: COMPLETED ·Phase: PHASE1
-
Assessing the Effect of Multiple Doses of Zibotentan on the Pharmacokinetics of Single Doses of Combined Oral Contraceptives in Healthy Female Participants of Non-childbearing Potential.
NCT05505162 ·Status: COMPLETED ·Phase: PHASE1
-
A Study in Healthy Women to Test Whether BI 1358894 Influences the Amount of a Contraceptive in the Blood
NCT05934942 ·Status: TERMINATED ·Phase: PHASE1
-
An Evaluation of the Pharmacokinetics of an Oral Contraceptive (Brevicon) When Co-administered With Albiglutide .
NCT01077505 ·Status: COMPLETED ·Phase: PHASE1
-
Low Dose Continuous Administration of the Progesterone Receptor Modulator VA2914
NCT00456924 ·Status: COMPLETED ·Phase: PHASE2
-
Study of Safety and Efficacy of an Oral Contraceptive
NCT00477633 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety of Two Flexible Extended Regimens of BAY86-5300 (SH T00186D) in Comparison With the Conventional Regimen of YAZ
NCT00567164 ·Status: COMPLETED ·Phase: PHASE3